SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 64 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $921,262 | -55.6% | 1,039,799 | -21.3% | 0.00% | -100.0% |
Q3 2022 | $2,074,000 | -6.8% | 1,320,592 | +19.3% | 0.00% | 0.0% |
Q2 2022 | $2,225,000 | -28.7% | 1,106,556 | -17.4% | 0.00% | 0.0% |
Q1 2022 | $3,120,000 | -42.5% | 1,339,186 | +14.8% | 0.00% | 0.0% |
Q4 2021 | $5,424,000 | -23.2% | 1,166,363 | +26.0% | 0.00% | -50.0% |
Q3 2021 | $7,060,000 | -11.8% | 925,445 | +12.0% | 0.00% | 0.0% |
Q2 2021 | $8,009,000 | +21.6% | 826,533 | +3.7% | 0.00% | +100.0% |
Q1 2021 | $6,589,000 | -5.4% | 796,850 | -21.9% | 0.00% | -50.0% |
Q4 2020 | $6,965,000 | -18.7% | 1,020,563 | +25.0% | 0.00% | 0.0% |
Q3 2020 | $8,565,000 | +126.3% | 816,604 | +35.5% | 0.00% | +100.0% |
Q2 2020 | $3,784,000 | +2810.8% | 602,493 | +755.0% | 0.00% | – |
Q1 2020 | $130,000 | -73.2% | 70,468 | -50.9% | 0.00% | – |
Q4 2019 | $485,000 | +90.9% | 143,648 | +20.8% | 0.00% | – |
Q3 2019 | $254,000 | -17.5% | 118,882 | +2.9% | 0.00% | – |
Q2 2019 | $308,000 | -68.8% | 115,540 | -44.5% | 0.00% | – |
Q1 2019 | $988,000 | +127.1% | 208,203 | +14.9% | 0.00% | – |
Q4 2018 | $435,000 | -35.7% | 181,234 | +17.7% | 0.00% | – |
Q3 2018 | $677,000 | -84.6% | 153,917 | -74.8% | 0.00% | -100.0% |
Q2 2018 | $4,406,000 | +70.7% | 611,968 | +22.1% | 0.00% | 0.0% |
Q1 2018 | $2,581,000 | +25710.0% | 501,200 | +19948.0% | 0.00% | – |
Q4 2017 | $10,000 | +150.0% | 2,500 | 0.0% | 0.00% | – |
Q3 2017 | $4,000 | -98.9% | 2,500 | -97.3% | 0.00% | – |
Q1 2017 | $362,000 | -41.0% | 91,593 | -26.9% | 0.00% | – |
Q4 2016 | $614,000 | +372.3% | 125,261 | +644.0% | 0.00% | – |
Q3 2016 | $130,000 | +30.0% | 16,837 | -5.6% | 0.00% | – |
Q2 2016 | $100,000 | -16.7% | 17,837 | -20.6% | 0.00% | – |
Q1 2016 | $120,000 | -31.0% | 22,454 | +12.5% | 0.00% | – |
Q4 2015 | $174,000 | +5.5% | 19,959 | +1.5% | 0.00% | – |
Q3 2015 | $165,000 | -24.7% | 19,669 | +58.4% | 0.00% | – |
Q2 2015 | $219,000 | -37.8% | 12,421 | -59.2% | 0.00% | – |
Q1 2015 | $352,000 | – | 30,428 | +3042700.0% | 0.00% | – |
Q4 2014 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2014 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2014 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q1 2014 | $81,000 | – | 6,298 | +629700.0% | 0.00% | – |
Q4 2013 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
Aristides Capital LLC | 24,302 | $271,000 | 0.19% |